Javascript must be enabled to continue!
Biomarkers of endothelial activation and dysfunction in cardiovascular diseases
View through CrossRef
Endothelial activation and dysfunction is an important contributor to atherosclerosis, cardiovascular diseases and cardiorenal syndrome. Endothelial dysfunction is also linked with metabolic syndrome and type II diabetes. The search for specific and sensitive biomarkers of endothelial activation and dysfunction may have important clinical implications. This review pinpoints the differences in biomarkers between endothelial activation and endothelial dysfunction in cardiovascular diseases, and then briefly describes the most relevant biomarkers of endothelial activation. Biomarkers of endothelial activation include endothelial adhesion molecules, cytokines, C-reactive protein, CD62E+/E-selectin activated endothelial microparticles, oxidation of low density lipoproteins, asymmetric dimethylarginine and endocan. This review also presents an update on the novel biomarkers of endothelial dysfunction, such as matrix metalloproteinases (e.g., MMP-7, MMP-9), ANGPTL2, endogdlin, annexin V+ endothelial apoptotic microparticles, and serum homocysteine. Finally, this review emphasizes the limitations of biomarkers of endothelial activation and dysfunction in clinical setting.
Title: Biomarkers of endothelial activation and dysfunction in cardiovascular diseases
Description:
Endothelial activation and dysfunction is an important contributor to atherosclerosis, cardiovascular diseases and cardiorenal syndrome.
Endothelial dysfunction is also linked with metabolic syndrome and type II diabetes.
The search for specific and sensitive biomarkers of endothelial activation and dysfunction may have important clinical implications.
This review pinpoints the differences in biomarkers between endothelial activation and endothelial dysfunction in cardiovascular diseases, and then briefly describes the most relevant biomarkers of endothelial activation.
Biomarkers of endothelial activation include endothelial adhesion molecules, cytokines, C-reactive protein, CD62E+/E-selectin activated endothelial microparticles, oxidation of low density lipoproteins, asymmetric dimethylarginine and endocan.
This review also presents an update on the novel biomarkers of endothelial dysfunction, such as matrix metalloproteinases (e.
g.
, MMP-7, MMP-9), ANGPTL2, endogdlin, annexin V+ endothelial apoptotic microparticles, and serum homocysteine.
Finally, this review emphasizes the limitations of biomarkers of endothelial activation and dysfunction in clinical setting.
Related Results
Susceptibility towards Irradiation-Induced Bone Marrow (BM) Dysplasia in Vivo Is Determined by the BM Vasculogenic Phenotype: Correlation with MDS Patients BM Samples
Susceptibility towards Irradiation-Induced Bone Marrow (BM) Dysplasia in Vivo Is Determined by the BM Vasculogenic Phenotype: Correlation with MDS Patients BM Samples
Abstract
Bone marrow (BM) endothelial cells regulate hematopoiesis by promoting mobilization, survival and proliferation of hematopoietic progenitors. Interfering wi...
Breast Cancer Susceptibility Gene 2 Deficiency Exacerbates Angiotensin‐II‐induced Endothelial Dysfunction and Apoptosis
Breast Cancer Susceptibility Gene 2 Deficiency Exacerbates Angiotensin‐II‐induced Endothelial Dysfunction and Apoptosis
BackgroundGerm‐line mutations in the tumour suppressor genes BRCA1 and BRCA2 (BReast CAncer susceptibility genes 1 & 2) predispose carriers to breast cancer. BRCA1 and BRCA2 he...
Abstract 690: Endothelial-Specific Krüppel-Like Factor 2 Inactivation Promotes Endothelial Dysfunction in the Setting of Uremia
Abstract 690: Endothelial-Specific Krüppel-Like Factor 2 Inactivation Promotes Endothelial Dysfunction in the Setting of Uremia
Background:
Uremic solutes that accumulate in end-stage renal disease (ESRD) contribute to endothelial dysfunction and subsequent cardiovascular disease in ESRD patient...
The Effects of Xanthine Oxidase Inhibitors on the Management of Cardiovascular Diseases
The Effects of Xanthine Oxidase Inhibitors on the Management of Cardiovascular Diseases
Cardiovascular diseases (CVDs) are the fastest-growing cause of death around the world, and atherosclerosis plays a major role in the etiology of CVDs. The most recent figures show...
Crocus Sativusand Its Active Compound, Crocin Inhibits the Endothelial Activation and Monocyte-Endothelial Cells Interaction in Stimulated Human Coronary Artery Endothelial Cells
Crocus Sativusand Its Active Compound, Crocin Inhibits the Endothelial Activation and Monocyte-Endothelial Cells Interaction in Stimulated Human Coronary Artery Endothelial Cells
AbstractCrocus sativus L.or saffron has been shown to have anti-atherogenic effects. However, its effects on key events in atherogenesis such as endothelial activation and monocyte...
Abstract 42: Chronic Endothelial Activation in Childhood Arterial Ischemic Stroke
Abstract 42: Chronic Endothelial Activation in Childhood Arterial Ischemic Stroke
Objective:
Despite evidence suggesting that arterial inflammation plays a role in the pathophysiology of childhood arterial ischemic stroke (AIS), relatively little is ...
Endothelial TRPV4 mitigates obesity-induced metabolic inflammation via Ca2+-dependent eNOS phosphorylation
Endothelial TRPV4 mitigates obesity-induced metabolic inflammation via Ca2+-dependent eNOS phosphorylation
Rationale: Previous studies show endothelial Ca2+ permeable channel TRPV4 (transient receptor potential channel family V isoform 4) as a vasodilator defense against endothelial dys...
Association between dog and cat ownership with cardiovascular disease: A systematic review and meta-analysis
Association between dog and cat ownership with cardiovascular disease: A systematic review and meta-analysis
Background: Numerous studies have described the correlation of pet ownership with cardiovascular diseases, with dog and cat ownership emerging as the predominant forms of pet compa...

